Solution conformations of potent bicyclic antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations

Mark D. Shenderovich, K. Kövér, Susanne Wilke, Nathan Collins, Victor J. Hruby

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The solution conformations of two potent bicyclic antagonists of oxytocin (H-Cys1-Tyr2-Ile3-Gln4- Asn5-Cys6-Pro7-Leu8-Gly9-NH2, OT). [Mpa1,cyclo(Glu4,Lys8)]OT, and [dPen1, cyclo(Glu4,Lys8)]OT were studied by a combined use of 1H and 13C NMR spectroscopy in DMSO and molecular dynamics (MD) simulations. NMR data have suggested a model for the three- dimensional (3D) structure of the bicyclic analogues of OT (OT-BC) with a β- turn at the Tyr2 and Ile3 residues, and with a cis amide bond between Cys6 and Pro7. A 3D structure containing a type III β-turn at Tyr2-Ile3 has been shown to be consistent with NMR data. This structure was proposed as a model of the solution conformation of OT-BC and extensively tested by MD simulations with the AMBER force field. MD simulations at 300 K with NMR derived distance and Φ torsion angle constraints demonstrated the consistency of this model with NMR data, and its stability was further demonstrated by non-constrained MD simulations. Dynamic properties of the 3D structure were explored by high-temperature MD at 500 K. Conformational transitions induced by a constrained rotation around the S-S bond revealed relatively low potential energy barriers 130 to 50 kJ/mol) between equilibrium left-handed and right-handed conformers of the disulfide bridge in OT-BC. A dynamic model of the solution structure of OT-BC with the relatively stable backbone conformation and a fast conformational equilibrium in the disulfide bridge and lactam bridge moieties was proposed as a result of the extensive MD simulations. The solution structure of OT-BC is consistent with structure-activity relations of peptide and non-peptide antagonists of OT. In particular, a β-turn at Tyr2-Ile3 seems to be the common feature responsible for antagonist interaction with the uterine receptor of OT. On the other hand, the 3D structure of OT-BC differs considerably from the crystal and solution structures of OT analogues with agonist activity. Therefore, this study supports the hypothesis of different modes of receptor binding for agonists and antagonists of OT. The model of 3D structure of OT-BC proposed in this study may be used as a template for the rational design of peptide and non-peptide antagonists of oxytocin.

Original languageEnglish
Pages (from-to)5833-5846
Number of pages14
JournalJournal of the American Chemical Society
Volume119
Issue number25
DOIs
Publication statusPublished - 1997

Fingerprint

Oxytocin
Molecular Dynamics Simulation
Nuclear magnetic resonance spectroscopy
Conformations
Molecular dynamics
Magnetic Resonance Spectroscopy
Computer simulation
Nuclear magnetic resonance
Disulfides
Peptides
Lactams
Energy barriers
Dimethyl Sulfoxide
Potential energy
Amides
Torsional stress
Dynamic models
Crystals
Temperature

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Solution conformations of potent bicyclic antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations. / Shenderovich, Mark D.; Kövér, K.; Wilke, Susanne; Collins, Nathan; Hruby, Victor J.

In: Journal of the American Chemical Society, Vol. 119, No. 25, 1997, p. 5833-5846.

Research output: Contribution to journalArticle

@article{5f51453a80b04c08abad01ba2928450d,
title = "Solution conformations of potent bicyclic antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations",
abstract = "The solution conformations of two potent bicyclic antagonists of oxytocin (H-Cys1-Tyr2-Ile3-Gln4- Asn5-Cys6-Pro7-Leu8-Gly9-NH2, OT). [Mpa1,cyclo(Glu4,Lys8)]OT, and [dPen1, cyclo(Glu4,Lys8)]OT were studied by a combined use of 1H and 13C NMR spectroscopy in DMSO and molecular dynamics (MD) simulations. NMR data have suggested a model for the three- dimensional (3D) structure of the bicyclic analogues of OT (OT-BC) with a β- turn at the Tyr2 and Ile3 residues, and with a cis amide bond between Cys6 and Pro7. A 3D structure containing a type III β-turn at Tyr2-Ile3 has been shown to be consistent with NMR data. This structure was proposed as a model of the solution conformation of OT-BC and extensively tested by MD simulations with the AMBER force field. MD simulations at 300 K with NMR derived distance and Φ torsion angle constraints demonstrated the consistency of this model with NMR data, and its stability was further demonstrated by non-constrained MD simulations. Dynamic properties of the 3D structure were explored by high-temperature MD at 500 K. Conformational transitions induced by a constrained rotation around the S-S bond revealed relatively low potential energy barriers 130 to 50 kJ/mol) between equilibrium left-handed and right-handed conformers of the disulfide bridge in OT-BC. A dynamic model of the solution structure of OT-BC with the relatively stable backbone conformation and a fast conformational equilibrium in the disulfide bridge and lactam bridge moieties was proposed as a result of the extensive MD simulations. The solution structure of OT-BC is consistent with structure-activity relations of peptide and non-peptide antagonists of OT. In particular, a β-turn at Tyr2-Ile3 seems to be the common feature responsible for antagonist interaction with the uterine receptor of OT. On the other hand, the 3D structure of OT-BC differs considerably from the crystal and solution structures of OT analogues with agonist activity. Therefore, this study supports the hypothesis of different modes of receptor binding for agonists and antagonists of OT. The model of 3D structure of OT-BC proposed in this study may be used as a template for the rational design of peptide and non-peptide antagonists of oxytocin.",
author = "Shenderovich, {Mark D.} and K. K{\"o}v{\'e}r and Susanne Wilke and Nathan Collins and Hruby, {Victor J.}",
year = "1997",
doi = "10.1021/ja963736y",
language = "English",
volume = "119",
pages = "5833--5846",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "25",

}

TY - JOUR

T1 - Solution conformations of potent bicyclic antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations

AU - Shenderovich, Mark D.

AU - Kövér, K.

AU - Wilke, Susanne

AU - Collins, Nathan

AU - Hruby, Victor J.

PY - 1997

Y1 - 1997

N2 - The solution conformations of two potent bicyclic antagonists of oxytocin (H-Cys1-Tyr2-Ile3-Gln4- Asn5-Cys6-Pro7-Leu8-Gly9-NH2, OT). [Mpa1,cyclo(Glu4,Lys8)]OT, and [dPen1, cyclo(Glu4,Lys8)]OT were studied by a combined use of 1H and 13C NMR spectroscopy in DMSO and molecular dynamics (MD) simulations. NMR data have suggested a model for the three- dimensional (3D) structure of the bicyclic analogues of OT (OT-BC) with a β- turn at the Tyr2 and Ile3 residues, and with a cis amide bond between Cys6 and Pro7. A 3D structure containing a type III β-turn at Tyr2-Ile3 has been shown to be consistent with NMR data. This structure was proposed as a model of the solution conformation of OT-BC and extensively tested by MD simulations with the AMBER force field. MD simulations at 300 K with NMR derived distance and Φ torsion angle constraints demonstrated the consistency of this model with NMR data, and its stability was further demonstrated by non-constrained MD simulations. Dynamic properties of the 3D structure were explored by high-temperature MD at 500 K. Conformational transitions induced by a constrained rotation around the S-S bond revealed relatively low potential energy barriers 130 to 50 kJ/mol) between equilibrium left-handed and right-handed conformers of the disulfide bridge in OT-BC. A dynamic model of the solution structure of OT-BC with the relatively stable backbone conformation and a fast conformational equilibrium in the disulfide bridge and lactam bridge moieties was proposed as a result of the extensive MD simulations. The solution structure of OT-BC is consistent with structure-activity relations of peptide and non-peptide antagonists of OT. In particular, a β-turn at Tyr2-Ile3 seems to be the common feature responsible for antagonist interaction with the uterine receptor of OT. On the other hand, the 3D structure of OT-BC differs considerably from the crystal and solution structures of OT analogues with agonist activity. Therefore, this study supports the hypothesis of different modes of receptor binding for agonists and antagonists of OT. The model of 3D structure of OT-BC proposed in this study may be used as a template for the rational design of peptide and non-peptide antagonists of oxytocin.

AB - The solution conformations of two potent bicyclic antagonists of oxytocin (H-Cys1-Tyr2-Ile3-Gln4- Asn5-Cys6-Pro7-Leu8-Gly9-NH2, OT). [Mpa1,cyclo(Glu4,Lys8)]OT, and [dPen1, cyclo(Glu4,Lys8)]OT were studied by a combined use of 1H and 13C NMR spectroscopy in DMSO and molecular dynamics (MD) simulations. NMR data have suggested a model for the three- dimensional (3D) structure of the bicyclic analogues of OT (OT-BC) with a β- turn at the Tyr2 and Ile3 residues, and with a cis amide bond between Cys6 and Pro7. A 3D structure containing a type III β-turn at Tyr2-Ile3 has been shown to be consistent with NMR data. This structure was proposed as a model of the solution conformation of OT-BC and extensively tested by MD simulations with the AMBER force field. MD simulations at 300 K with NMR derived distance and Φ torsion angle constraints demonstrated the consistency of this model with NMR data, and its stability was further demonstrated by non-constrained MD simulations. Dynamic properties of the 3D structure were explored by high-temperature MD at 500 K. Conformational transitions induced by a constrained rotation around the S-S bond revealed relatively low potential energy barriers 130 to 50 kJ/mol) between equilibrium left-handed and right-handed conformers of the disulfide bridge in OT-BC. A dynamic model of the solution structure of OT-BC with the relatively stable backbone conformation and a fast conformational equilibrium in the disulfide bridge and lactam bridge moieties was proposed as a result of the extensive MD simulations. The solution structure of OT-BC is consistent with structure-activity relations of peptide and non-peptide antagonists of OT. In particular, a β-turn at Tyr2-Ile3 seems to be the common feature responsible for antagonist interaction with the uterine receptor of OT. On the other hand, the 3D structure of OT-BC differs considerably from the crystal and solution structures of OT analogues with agonist activity. Therefore, this study supports the hypothesis of different modes of receptor binding for agonists and antagonists of OT. The model of 3D structure of OT-BC proposed in this study may be used as a template for the rational design of peptide and non-peptide antagonists of oxytocin.

UR - http://www.scopus.com/inward/record.url?scp=0030788469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030788469&partnerID=8YFLogxK

U2 - 10.1021/ja963736y

DO - 10.1021/ja963736y

M3 - Article

AN - SCOPUS:0030788469

VL - 119

SP - 5833

EP - 5846

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 25

ER -